Literature DB >> 10221944

Agranulocytosis associated with lamotrigine.

O A de Camargo1, H Bode.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221944      PMCID: PMC27855          DOI: 10.1136/bmj.318.7192.1179a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Safety of long-term lamotrigine in epilepsy.

Authors:  F J Mackay; L V Wilton; G L Pearce; S N Freemantle; R D Mann
Journal:  Epilepsia       Date:  1997-08       Impact factor: 5.864

2.  Leucopenia associated with lamotrigine.

Authors:  R J Nicholson; K P Kelly; I S Grant
Journal:  BMJ       Date:  1995-02-25
  2 in total
  5 in total

1.  Lamotrigine-induced neutropenia in a woman with schizoaffective disorder.

Authors:  Piyush Das; Sriram Ramaswamy; Monica Arora; Irina Samuels; Teri L Gabel
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 2.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Newer anticonvulsants: comparative review of drug interactions and adverse effects.

Authors:  A Sabers; L Gram
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

5.  Three cases of reversible agranulocytosis after treatment with lamotrigine.

Authors:  Yong Min Ahn; Kunjong Kim; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.